MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

BioChromato - ionRocket

BioChromato launches ionRocket for rapid, direct mass spectrometry characterisation of difficult samples

Laboratory, 26 March 2021/in Product News /by panglobal

BioChromata - ionRocket

The ionRocket from BioChromato is a temperature-heating device for direct thermal desorption and pyrolysis of samples, prior to ionization and analysis by mass spectrometry.

Direct Analysis in Real Time Mass Spectrometry (DART-MS) is a proven technique that enables rapid analysis of both solid and liquid samples under standard laboratory conditions without sample preparation. However, certain polymers, cosmetic powders and forensic materials are difficult to analyse using DART-MS due to the varying volatility of substituents in these complex samples. Even insoluble samples can be measured using the ionRocket / DART-MS set-up without treatment.

To overcome these challenges, BioChromato developed an innovative sample introduction device (ionRocket), which gradually heats a sample placed directly beneath the DART-MS gas stream. Gradient heating of the sample before ionization creates time/temperature resolved mass spectra, separating species both by their thermal desorption profiles and mass to charge ratio (m/z). 

ionRocket generates a temperature gradient from ambient up to as high as 600ºC in just a few minutes. This allows compounds in your samples to be sublimated, vaporized, or pyrolyzed according to their volatility, and then introduced into the DART-MS gas stream. Because the ionRocket offers the option to weigh samples prior to analysis this results in reproducible MS intensity, allowing calibration curves of analyte amount versus peak intensity to be calculated.

Data obtained from ionRocket yields another axis of data (time/temperature) beyond that obtained from normal DART-MS analysis. Species desorb in order of their volatility along the temperature gradient, and therefore are separated in time. The data produced resembles that of an LC-MS or GC-MS chromatogram, consisting of temperature/time, m/z, and intensity. This can separate rare from abundant species, making them easier to detect.

  • For more information, visit: https://biochromato.com/analyticalinstruments/ionrocket
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/biochromato_ionrocket.jpg 517 894 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-03-26 08:48:392021-03-26 08:48:39BioChromato launches ionRocket for rapid, direct mass spectrometry characterisation of difficult samples
The Thermo Scientific General Purpose Pro Centrifuge Series deliver optimal sample safety functionality and ergonomics

Thermo Fisher introduces 2 new centrifuges

, 16 March 2021/in Product News /by panglobal
Thermo Fisher Scientific General Purpose Pro Centrifuge Series

The new 1.6 L benchtop and 4 L floor-standing systems complete the General Purpose Pro Centrifuge Series

Thermo Fisher Scientific has further expanded its Thermo Scientific General Purpose Pro Centrifuge Series with the addition of two new models designed to meet the needs of biopharmaceutical, cell and gene therapy, and academic research laboratories, as well as clinical diagnostic facilities, for enhanced sample safety and reproducibility, improved ergonomics and reduced noise levels.

The new 1.6 L benchtop and 4 L floor-standing systems complete the General Purpose Pro Centrifuge Series, completing a comprehensive family of products to address varying sample capacity and laboratory space requirements. Like the other systems in the series, the new models feature a unique full colour, glass touchscreen display that facilitates a simple user interface for immediate, effortless workflow and operation monitoring, as well as easy cleaning. As a result, laboratories benefit from an advanced level of functionality and improved efficiencies.

High-speed

A new high-speed rotor complements the 4 L models providing the ability to run both microplates and tubes. Built with versatility in mind, the complete General Purpose Pro Centrifuge Series offers 24 different rotor options in total — including 11 swinging bucket and 13 fixed angle rotors — which can be used interchangeably to align with various application needs, from cell culture procedures and microplate processing to cell and gene therapy manufacturing and clinical protocols. The systems’ ergonomically enhanced, novel industrial design enables the quick and safe change of any of the 24 rotor types in just three seconds through the Auto-Lock Rotor Exchange function.

“Centrifuges are an integral part of biopharmaceutical, cell and gene therapy, academic research and clinical diagnostic laboratories, but installation can be a time and resource intensive task, requiring manual entry of run parameters, as well as transport and connection of rotors,” said Carlos Sevilla, general manager for centrifugation at Thermo Fisher Scientific. “Drawing from our proven centrifugation expertise, the General Purpose Pro Centrifuge Series address these challenges, boasting technologies designed to push the boundaries of performance and usability for our customers’ unmet needs.”

General Purpose Pro Centrifuge Series

The General Purpose Pro Centrifuge Series includes the Thermo Scientific Sorvall, Thermo Scientific Multifuge and Thermo Scientific Megafuge systems, all of which meet the latest global IVD standards and medical regulations. Superior sample capacity and performance are enabled through the systems’ Fiberlite Carbon Fiber Rotors, while the certified ClickSeal Biocontainment Lids ensure personnel and laboratory environment safety and security.

More information
For more information visit: www.thermofisher.com

https://clinlabint.com/wp-content/uploads/sites/2/2021/03/The-Thermo-Scientific-General-Purpose-Pro-Centrifuge-Series-deliver-optimal-sample-safety-functionality-and-ergonomics-scaled.jpg 1920 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-03-16 13:43:492021-03-16 13:43:49Thermo Fisher introduces 2 new centrifuges
SARS-CoV-2

BBI Solutions launches two new SARS-Cov-2 antigens as raw materials for IVD manufacturers

, 16 March 2021/in Product News /by panglobal

SARS-CoV-2

BBI’s recently-acquired and well-respected team based in Freiburg, Germany (DIARECT GmbH) has developed two new recombinant antigen preparations produced in Baculovirus transfected Sf9 cells.

The antigens Nucleocapsid (N) protein and Spike (S) glycoprotein Receptor Binding Domain (RBD) have been designed as critical raw materials for next generation serological assays.

With the continuing COVID-19 vaccination programme, testing for antibody response will become increasingly important. Antibody tests detecting immune response to both the conserved and abundant nucleocapsid and the receptor binding domain that is unique for the SARS-CoV-2, will deliver physicians important information for disease management.

Serology testing is strongly suggested to play a major role in screening populations to determine exposure, as well as potential immunity, to identify recovering individuals as plasma donors as well as for research on immune response and to help identify neutralising antibodies (Amanat et al. 2020; Farnsworth and Anderson 2020; Okba et al. 2020).

Seven manufacturing sites across four continents

BBI Solutions has seven manufacturing sites across four continents and has an established reputation as a leading manufacturer of biological reagents and finished test platforms for the in-vitro diagnostics market. The lateral flow manufacturing centre of excellence in Wales, UK is also part of the UK-Rapid Test Consortium (UK-RTC).

BBI Solutions acquired the Germany-based specialist manufacturer of autoimmune, infectious disease and allergy antigens DIARECT last year. This launch is the latest of new products in the pipeline. BBI’s two novel antigens are produced and characterised in the company’s ISO 13485:2016 compliant laboratories in Freiburg, Germany.

Dr Mario Gualano, Chief Executive of BBI Group, said: “These recombinant antigens are a welcome addition to our product catalogue and complement our existing range. We were delighted that our expertise in Freiburg can add a further component to the support BBI can offer the IVD industry in the fight against this pandemic.”

  • For more information, visit: bbisolutions.com
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/SARS-CoV-2.jpg 801 801 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-03-16 13:31:522021-03-16 13:31:52BBI Solutions launches two new SARS-Cov-2 antigens as raw materials for IVD manufacturers
CLI 210223 doc imatge KLoneus

KLoneus® Free Light Chain (FLC) assays, for Turdidimetry and Nephelometry

, 2 March 2021/in Product News /by 3wmedia

TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/CLI_210223_doc_imatge_KLoneus.jpg 883 723 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-03-02 09:44:252021-03-02 09:46:47KLoneus® Free Light Chain (FLC) assays, for Turdidimetry and Nephelometry
porvairepromo2020E image

Optimised Microplates for Affinity Binding Assays

, 2 March 2021/in Product News /by 3wmedia

Medium and high bind Krystal microplates from Porvair Sciences set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as Enzyme-Linked Immunosorbent Assay (ELISA). Manufactured from high-quality crystal polystyrene – these new automation-ready plates are available in a choice of ANSI / SLAS standard (96-well […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/porvairepromo2020E-image-.jpg 1240 1748 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-03-02 09:33:112021-03-02 09:40:07Optimised Microplates for Affinity Binding Assays
VACUETTE FC Mix Tube

Greiner Bio-One introduces VACUETTE FC Mix Tube for effective glycolysis inhibition

, 16 February 2021/in Product News /by callan

VACUETTE FC Mix Tube

Greiner Bio-One has introduced VACUETTE FC Mix Tube for effective glycolysis inhibition for precise determination of the in vivo blood sugar content.

The time from collection until separation of plasma and cells, temperature as well as cell count strongly affect glucose levels possibly leading to false low results. Unfortunately, fluoride alone is not able to stabilize the real in-vivo glucose level completely.

VACUETTE FC Mix Tubes are citrated and therefore can help to prevent the initial loss of glucose within the first few hours from collection until fluoride shows its effect. Buffered Na2EDTA, citric acid, sodium citrate and sodium fluoride are used to decrease the pH and block the pH dependent enzymes, which would be active in the initial stage of the glycolysis cascade.

  • More information, visit: gbo.com
https://clinlabint.com/wp-content/uploads/sites/2/2021/02/VACUETTE_glucose_FC.png 492 612 callan https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png callan2021-02-16 07:57:342021-02-16 07:57:34Greiner Bio-One introduces VACUETTE FC Mix Tube for effective glycolysis inhibition
SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test

SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test

, 16 February 2021/in Product News /by callan

SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test

SEKISUI Diagnostics has launched the OSOM Ultra Plus Flu A&B Test. The test utilizes traditional lateral flow technology with performance near or exceeding sensitivity of other reader-based tests without using an instrument. It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

 

High performance, point-of-care rapid test for the detection of Influenza A&B

  • Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
  • Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
  • Sensitivity
    • A: 90.3%
    • B: 88.0%
  • Specificity
    • A: 96.7%
    • B: 99.2%
https://clinlabint.com/wp-content/uploads/sites/2/2021/02/OSOM-UP-Flu-AB.jpg 1177 1417 callan https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png callan2021-02-16 07:31:582021-02-16 07:31:58SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test
CLI 201229 doc image IgD

IgD Immunoglobulin assays for nephelometry (IMMAGE® and BN™ series) and turbidimetry

, 2 February 2021/in Product News /by TRIMERO DIAGNOSTICS

TRIMERO Diagnostics offers IVD CE marked assays for testing IgD Immunoglobulins (IgD) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/02/CLI_201229_doc_image_IgD.jpg 883 722 TRIMERO DIAGNOSTICS https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png TRIMERO DIAGNOSTICS2021-02-02 15:09:112021-02-16 11:25:01IgD Immunoglobulin assays for nephelometry (IMMAGE® and BN™ series) and turbidimetry
Erba Mannheim SARS-CoV-2 RT-PCR Assay

ERBA Mannheim launches 2nd generation SARS-CoV-2 RT-PCR Assay with room temperature storage

, 2 February 2021/in Product News, Corona News /by callan

Erba Mannheim SARS-CoV-2 RT-PCR Assay

In response to the ongoing COVID-19 pandemic, Erba Mannheim has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2.

To overcome challenges in older COVID-19 molecular tests, Erba’s Cambridge(UK)-based development team has engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation.

The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva.

Nikhil Vazirani, MD of Erba, said: “We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination.”

The CE-marked kit will be available through Erba’s global distribution network.

Erba Mannheim, established in over 100 countries, focusses on delivering innovative, affordable and sustainable diagnostic solutions to labs everywhere. The Erba group uses a combination of cutting-edge R&D in 4 continents with efficient low-cost manufacturing to make diagnostic technologies accessible in all resource settings.

  • For more information, visit: https://covid19.erbamannheim.com/
https://clinlabint.com/wp-content/uploads/sites/2/2021/02/erba.jpg 1321 1984 callan https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png callan2021-02-02 09:17:062021-02-02 16:00:58ERBA Mannheim launches 2nd generation SARS-CoV-2 RT-PCR Assay with room temperature storage
1A PRODUCT SIEMENS

Siemens Healthineers’ IL-6 Test receives U.S. FDA EUA to help assess dysregulated inflammation in COVID-19 patients

, 27 January 2021/in Product News /by 3wmedia

Siemens Healthineers announced 7 January that the U.S. FDA has issued an Emergency Use Authorization (EUA) for their laboratory-based IL-6 assay to measure the presence of Interleukin-6 (IL-6) in human serum or plasma. IL-6 is an indicator of potential severe inflammatory response in patients with confirmed SARS-CoV-2 infection. Emergency use of this test is limited […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/1A_PRODUCT_SIEMENS.jpg 479 693 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 00:35:072021-02-09 15:20:18Siemens Healthineers’ IL-6 Test receives U.S. FDA EUA to help assess dysregulated inflammation in COVID-19 patients
Page 65 of 152«‹6364656667›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription